News for AFT Pharmaceuticals Limited (AFP.AX)

Banks led the market lower and Macquarie (ASX:MQG) shed 3.6% after first half FY25 results missed estimates and disappointed investors.

The ASX200 closed down more than 2% at 7,943 points. Despite hitting a fresh all-time record yesterday, the bourse retreated down below the 8,000 level.

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today announces an agreement with Hainan Haiyao Co. Ltd (Shenzhen Stock Exchange SZ:000566) to distribute Crystaderm® cream in China, the second largest pharma market in the world*.

AFT Pharmaceuticals Ltd has announced a distribution deal with American wholesaler Alexso in relation to its Maxigesic Rapid tablets.

Results for announcement to the market AFT Pharmaceuticals Limited ...

AFT Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was NZD 195.41 million compared to NZD 156.64 million a year...

AFT Pharmaceuticals Ltd has reported record earnings for the year ended March 31, as well as growth in sales and lower debt.

May 21, 2023 / 10:00PM GMTOperator Thank you for standing by, and welcome to the AFT Pharmaceuticals 2023 Full Year Results Analyst Briefing. (Operator Instruct

Nov 23, 2022 / 09:00PM GMTOperator Thank you for standing by, and welcome to the AFT Pharmaceuticals FY 2023 Half Year Results Analyst Briefing. (Operator Instr

Aug 04, 2022 / 10:30PM GMTDavid Mark Flacks - AFT Pharmaceuticals Limited - Independent Chairman (foreign language) And good morning, everyone, and welcome to A

May 22, 2022 / 10:00PM GMTOperator Thank you for standing by, and welcome to the AFT Pharmaceuticals 2022 Full Year Results Analyst Briefing. (Operator Instruct

May 23, 2021 / 10:00PM GMTHartley Atkinson - AFT Pharmaceuticals Limited - Founder, CEO, MD & Executive Director Good. Thank you very much, and thanks for joini

Sep 07, 2020 / 10:30PM GMTDavid M. Flacks - AFT Pharmaceuticals Limited - Independent Chairman Okay. (foreign language) Kia ora and good morning, and welcome to

Nov 20, 2019 / 09:00PM GMTOperator Ladies and gentlemen, thank you for standing by and welcome to the AFT Pharmaceuticals half year results analyst briefing. (O

AFT Pharmaceuticals Limited (OTCPK:AFTPF) Q2 2023 Results Conference Call November 23, 2022 04:00 PM ET Company Participants Dr.

Blood clot was top of biotech news this week after researchers revealed new discovery that could prevent it without risk of bleeding.

Like a teenager on a first date, Aussie markets opened enthusiastically, before wilting in a disappointing fashion, only to rise again.

Today’s biggest winners are led by mineral scanning tech company Orexplore (ASX:OXT) who’ve signed a $2.35m deal with OZ Minerals.

... | November 10, 2021